Pfizer in talks with India over expedited approval for COVID-19 vaccine
Pfizer is in discussions with the Indian government seeking an “expedited approval pathway” for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million. “Unfortunately, our vaccine is not registered in India although our application was submitted months ago,” he said. “We are […]
